Sickle cell disease: A global patient registry review

5Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Sickle cell disease (SCD) is one of the most common inherited diseases. This review identified and assessed key characteristics of the increasing number of SCD registries reporting patients data. Registries were identified through targeted searches. Registry publications/websites were assessed for availability of information on patient outcomes. Of 33 identified registries, 21 were still active. Data were available for demographics (97%), diagnosis/disease classification (91%), treatments (82%), hospitalization (52%), mortality (36%), comorbidities (36%) and quality of life (18%). Only three registries collected data on patient-reported outcomes (PROs), and only two on productivity loss. SCD registries are a valuable source of real-world information. There is a paucity of quality of life, patient-reported outcomes and productivity loss data.

Cite

CITATION STYLE

APA

Borecka, O., Ofori, A., Amini, F., & Llewellyn, S. (2022, November 1). Sickle cell disease: A global patient registry review. Future Rare Diseases. Newlands Press Ltd. https://doi.org/10.2217/frd-2022-0014

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free